Teicoplanin use in a Korean university hospital
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, JM | - |
dc.contributor.author | Kim, EA | - |
dc.date.available | 2021-02-22T16:17:05Z | - |
dc.date.issued | 2003-11 | - |
dc.identifier.issn | 1079-2082 | - |
dc.identifier.issn | 1535-2900 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/16151 | - |
dc.format.extent | 2 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | AMER SOC HEALTH-SYSTEM PHARMACISTS | - |
dc.title | Teicoplanin use in a Korean university hospital | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1093/ajhp/60.21.2256 | - |
dc.identifier.wosid | 000186408800017 | - |
dc.identifier.bibliographicCitation | AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, v.60, no.21, pp 2256 - 2257 | - |
dc.citation.title | AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | - |
dc.citation.volume | 60 | - |
dc.citation.number | 21 | - |
dc.citation.startPage | 2256 | - |
dc.citation.endPage | 2257 | - |
dc.type.docType | Letter | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | CLINICAL-EVALUATION | - |
dc.subject.keywordPlus | INFECTIONS | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | SAFETY | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.